Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabozantinib in HR+ metastatic breast cancer with bone involvement
NCT01441947Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2011
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabozantinib in breast cancer, sponsored by Massachusetts General Hospital. Started Oct 2011; status: completed.
02
Drugs
cabozantinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01441947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01441947.